Paperonium

Vaccines · Nat Med · 2022

One sentence: mRNA vaccines protect best against Omicron BA.2. The paper’s chart and summary: worst.

One results sentenceIts own chart11.9%Omicron BA.133.3%Omicron BA.1summary: highest33.3%Omicron BA.2 (tookover in early 2022)11.9%Omicron BA.2 (tookover in early 2022)summary: lowest
One results sentenceIts own chart11.9%Omicron BA.133.3%Omicron BA.1summary: highest33.3%Omicron BA.2(took over inearly 2022)11.9%Omicron BA.2(took over inearly 2022)summary: lowest

Predicted protection from mRNA vaccines against two Omicron strains

The paper says

The paper’s model predicts how well vaccines prevent COVID with symptoms, for Omicron strains whose protection had not yet been measured. One sentence in its results section says mRNA vaccines give 11.9% protection against Omicron BA.1 and 33.3% against BA.2, two of the four strains.

Its own data show

Two other parts of the paper reverse them. Its chart prints no numbers, but measuring the mRNA-vaccine bars against its 0–100% scale gives 33.3% for BA.1 and 11.9% for BA.2, give or take 0.2 points. Its opening summary agrees: of the four Omicron strains, protection is highest against BA.1 and lowest against BA.2.

33.3% protection means vaccinated people catch COVID with symptoms a third less often than unvaccinated people; 11.9%, about an eighth less. BA.2 took over from BA.1 in early 2022, so that sentence makes mRNA vaccines look best against the strain taking over; the paper predicts worst. The chart and summary are right; only that sentence is swapped.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance · Nat Med (2022) · doi:10.1038/s41591-022-01877-1